Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / PHARMACEUTICALS
-
Number of holders
-
78
-
Total 13F shares, excl. options
-
797,603
-
Shares change
-
-146,498
-
Total reported value, excl. options
-
$64,683,241
-
Value change
-
-$11,337,748
-
Number of buys
-
25
-
Number of sells
-
-43
-
Price
-
$81.13
Significant Holders of INVESCO EXCHANGE TRADED FD T - PHARMACEUTICALS (PJP) as of Q4 2021
96 filings reported holding PJP - INVESCO EXCHANGE TRADED FD T - PHARMACEUTICALS as of Q4 2021.
INVESCO EXCHANGE TRADED FD T - PHARMACEUTICALS (PJP) has 78 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 797,603 shares
.
Largest 10 shareholders include Peak Asset Management, LLC (123,113 shares), LPL Financial LLC (58,462 shares), WELLS FARGO & COMPANY/MN (52,717 shares), BANK OF AMERICA CORP /DE/ (51,837 shares), GOLDMAN SACHS GROUP INC (50,000 shares), MORGAN STANLEY (47,815 shares), UBS Group AG (47,595 shares), Federation des caisses Desjardins du Quebec (44,669 shares), U.S. Capital Wealth Advisors, LLC (23,258 shares), and DUMONT & BLAKE INVESTMENT ADVISORS LLC (20,711 shares).
This table shows the top 78 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.